Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Post by Alexandchoyon Mar 12, 2021 4:15pm
201 Views
Post# 32787816

Value of IPOT recent news has not been recognized by the mar

Value of IPOT recent news has not been recognized by the mar

Recent IPOT news of Importation LOI with Major Israeli Cannabis Manufacturer is a great move for them as it enables all imported material to be sold under the Isracann brand = immediate product and brand building. Their domestically grown cannabis from their large local facilities will then be introduced into their product line upon the commencement of cultivation. 

 

I think this is a very strong strategy for them as it ensures they are able to establish their brand at the earliest possible time, create distribution relationships, and solidify their position in the Israeli cannabis market. 

 

With those systems in place, when the wholly owned Isracann cannabis growth facilities are able to be cultivated, they will be able to sell their cannabis very efficiently = that is when major profit starts rolling in. 

 

Israel has the highest percentage of cannabis user per capita in the world and recreational legalization is imminent. Dipping last couple days to $0.32 today and IMO this is an easy pick up for Monday morning.

<< Previous
Bullboard Posts
Next >>